Valopicitabine
- Level
- Commodity
- Parent
- 51111600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51111663This classification denotes a pyrimidine antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I2T0B5G94M. European Medicines Agency schedules Valopicitabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB35614. Valopicitabine generally arises in the molecular formula C15H24N4O6. The term VALOPICITABINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 20, no. 1, 2006, list 55.) VALOPICITABINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule valopicitabine under HS 29349990 and SITC 51579. As of Q4 2014, VALOPICITABINE remains the US FDA Preferred Term for this commodity. Valopicitabine bears US NLM identifiers UMLS ID C1664150 and NCI Concept Code C66649. SMILES: O1C(N2CCC(NC2=O)N)C(O)(C(OC(=O)C(N)C(C)C)C1CO)C.
Same parent
Under 51111600 · 55Activities that produce or sell this
KBLI · 8Inherited from family 51110000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.